News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Phase 1 Trial Finds Potential Parkinson’s Vaccine, Affitope PD01A, to be Safe and Possibly Effective


(May 29, 2018) - Affiris’ experimental Parkinson’s vaccine, Affitope PD01A, is safe and effectively triggers an immune response against the alpha-synuclein (aSyn) protein, data from a series of four consecutive clinical trials show. Read more